EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Reactive Oxygen Species‐Responsive Polymeric Prodrug Nanoparticles for Selective and Effective Treatment of Inflammatory Diseases

Yaming Zhang, Lu Liu, Tianyi Wang, Cong Mao, Pengfei Shan, Chak Sing Lau, Zhongyu Li iD, Weisheng Guo, Weiping Wang iD

Advanced Healthcare Materials · 2023-11 · 12 (29)

DOI: 10.1002/adhm.202301394 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Healthcare Materials, online erschienen am 17.08.2023. Verfasst von Yaming Zhang und 8 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Pharmaceutical Biotechnology & Dr. Li Dak-Sum Research Centre & Department of Pharmacology and Pharmacy, Li Ka Shing Faculty …. Hauptthemen laut MEDLINE: Prodrugs, Nanoparticles. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Dr. Li Dak-Sum Research Centre, The University of Hong Kong, Li Ka Shing Faculty of Medicine, The University of Hong Kong, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

It is challenging to manage inflammatory diseases using traditional anti‐inflammatory drugs due to their limited efficacy and systemic side effects, which are a result of their lack of selectivity, poor stability, and low solubility. Herein, it reports the development of a novel nanoparticle system, called ROS‐CA‐NPs, which is formed using polymer‐cinnamaldehyde (CA) conjugates and is responsive to reactive oxygen species (ROS). ROS‐CA‐NPs exhibit excellent drug stability, tissue selectivity, and controlled drug release upon oxidative stress activation. Using mouse models of chronic rheumatoid arthritis and acute ulcerative colitis, this study demonstrates that the systemic administration of ROS‐CA‐NPs results in their accumulation at inflamed lesions and leads to greater therapeutic efficacy compared to traditional drugs. Furthermore, ROS‐CA‐NPs present excellent biocompatibility. The findings suggest that ROS‐CA‐NPs have the potential to be developed as safe and effective nanotherapeutic agents for a broad range of inflammatory diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ProdrugsNanoparticlesAnimalsMiceReactive Oxygen SpeciesPolymersAnti-Inflammatory Agents

Stichwörter der Autor:innen

ROS-responsive nanoparticlescinnamaldehydepolymeric prodrugsrheumatoid arthritisulcerative colitis

Substanzen

ProdrugsReactive Oxygen SpeciesPolymersAnti-Inflammatory Agents

Autor:innen und Institutionen

  • State Key Laboratory of Pharmaceutical Biotechnology & Dr. Li Dak-Sum Research Centre & Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China.
  • Department of Minimally Invasive Interventional Radiology, State Key Laboratory of Respiratory Disease, School of Biomedical Engineering & The Second Affiliated Hospital, Guangzhou Medical University, Guangzhou, 510260,…
  • College of Chemistry and Materials Engineering, Wenzhou University, Wenzhou, 325027, China.
  • Department of Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China.

ORCID-Profile: Zhongyu Li, Weiping Wang

Förderung

  • Dr. Li Dak-Sum Research Centre, The University of Hong Kong
  • Li Ka Shing Faculty of Medicine, The University of Hong Kong
  • National Natural Science Foundation of China
  • Natural Science Foundation of Guangdong Province of China

Zitieren

APA

Zhang, Y., Liu, L., Wang, T., Mao, C., Shan, P., Lau, C. S., Li, Z., Guo, W., & Wang, W. (2023). Reactive Oxygen Species‐Responsive Polymeric Prodrug Nanoparticles for Selective and Effective Treatment of Inflammatory Diseases. Advanced Healthcare Materials, 12(29). https://doi.org/10.1002/adhm.202301394

Vancouver

Zhang Y, Liu L, Wang T, Mao C, Shan P, Lau CS, et al. Reactive Oxygen Species‐Responsive Polymeric Prodrug Nanoparticles for Selective and Effective Treatment of Inflammatory Diseases. Advanced Healthcare Materials. 2023;12(29). doi:10.1002/adhm.202301394

BibTeX
@article{Zhang2023,
  author = {Zhang, Yaming and Liu, Lu and Wang, Tianyi and Mao, Cong and Shan, Pengfei and Lau, Chak Sing and Li, Zhongyu and Guo, Weisheng and Wang, Weiping},
  title = {Reactive Oxygen Species‐Responsive Polymeric Prodrug Nanoparticles for Selective and Effective Treatment of Inflammatory Diseases},
  journal = {Advanced Healthcare Materials},
  year = {2023},
  volume = {12},
  number = {29},
  doi = {10.1002/adhm.202301394}
}
Kostenlos starten →